Hematologic Diseases: all 476 studies
Page 3 of 5. Open to participants first (109), then studies with results posted, then the rest; newest registration first within each.
- Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationSuspendedNCT05993611Phase 1
- Naturopathic-pharmacological Consultation in HematologyCompletedNCT05982262Not applicable
- Hypnosis and Virtual Reality in Bone Marrow ExaminationCompletedNCT05982249Not applicable
- Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)CompletedNCT05907603Early Phase 1
- RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBLCompletedNCT05902845Early Phase 1
- Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological MalignanciesCompletedNCT05895994Early Phase 1
- A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in IndiaActive, not recruitingNCT05891249Phase 4
- Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction TherapyActive, not recruitingNCT05833438Phase 2
- Intervention to Address Psychosocial Needs Among Socially Disadvantaged Older Adults With CancerTerminatedNCT05828654Not applicable
- Evaluation of ClearLLab LS Screening PanelCompletedNCT05819762
- Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT05727917Not applicable
- Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.Status unknownNCT05719181Phase 1
- CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBLCompletedNCT05716113Early Phase 1
- Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological DisorderCompletedNCT05689450
- Hematological Disorders Associated With COVID-19 InfectionCompletedNCT05677750
- Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19CompletedNCT05675943Not applicable
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 YearsTerminatedNCT05660265Phase 1
- A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)TerminatedNCT05641324Phase 1
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 3
- A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesActive, not recruitingNCT05589896Phase 1/2
- Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell TransplantationWithdrawnNCT05587881
- Hematological Abnormalities in ChildrenStatus unknownNCT05541835
- Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with ErythrocytosisCompletedNCT05487794Not applicable
- Spectrum of Hematological Disorders in PediatricsStatus unknownNCT05473650
- Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)Active, not recruitingNCT05356195Phase 3
- Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight ManagementTerminatedNCT05351866Not applicable
- A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell DiseaseTerminatedNCT05348915Phase 3
- Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)Active, not recruitingNCT05329649Phase 3
- Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood DiseasesStatus unknownNCT05324917
- Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After TransplantActive, not recruitingNCT05317416Phase 3
- QIAstat-Dx® BCID Plus AMR Panels Clinical Performance StudyCompletedNCT05305534
- Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersWithdrawnNCT05293509Phase 2
- (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisActive, not recruitingNCT05186753Phase 2
- Hematological Disorders in Covid 19 PatientsStatus unknownNCT05182528
- A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension PeriodActive, not recruitingNCT05175105Phase 3
- Muscle Dysfunction in Patients With Haematological DiseasesActive, not recruitingNCT05150561
- mNGS Versus Blood Culture in FNStatus unknownNCT05149547
- A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal ImpairmentStatus unknownNCT05147493Phase 2
- A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension PeriodActive, not recruitingNCT05144256Phase 3
- Monitoring Risks for Hematological Changes in Gas Station WorkersStatus unknownNCT05135078
- Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy ProceduresWithdrawnNCT05102331Not applicable
- Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT05095116
- Collection and Distribution of Biospecimens for Novel ResearchStatus unknownNCT05080907
- Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center StudyCompletedNCT05074706
- Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home SettingCompletedNCT05041933
- Study of Oral LOXO-338 in Patients With Advanced Blood CancersCompletedNCT05024045Phase 1
- A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major ParticipantsCompletedNCT05015920Not applicable
- Effects of Music Therapy on Sleep Quality in Patients Who Had Hematopoietic Stem Cell TransplantationCompletedNCT05015140Not applicable
- Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs in Patients With Hematological Diseases in ChinaStatus unknownNCT05002582
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedNCT04987489Phase 2
- Research on the Application and Mechanism of New Biological Probes in BiomedicineCompletedNCT04977739
- AI Algorithms to Automate the TMI by VMAT Optimization Using WB-CT/MRI and Synthetic WB-CT - The AuToMI ProjectCompletedNCT04976205Not applicable
- A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Active, not recruitingNCT04965493Phase 3
- HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
- DSAs in Patients Undergoing Allo-HSCT From Mismatched DonorsCompletedNCT04888286
- Itacitinib for the Prevention of Graft Versus Host DiseaseActive, not recruitingNCT04859946Phase 2
- National Project on Vaccines, COVID-19 and Frail PatientsCompletedNCT04848493
- Covid-19 Vaccine Response in Immunocompromised Haematology PatientsCompletedNCT04805216
- A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMMActive, not recruitingNCT04786028Phase 2
- Laparoscopic Splenectomy in ChildrenCompletedNCT04763733Phase 1
- Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood DisordersActive, not recruitingNCT04761770Phase 2
- Central Nervous System Disorders Following Hematopoietic Stem Cell TransplantationCompletedNCT04737785
- Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy PatientsCompletedNCT04723706
- Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)Status unknownNCT04720144
- Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsCompletedNCT04684940Phase 1/2
- HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood DiseasesCompletedNCT04667702
- Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)Active, not recruitingNCT04662255Phase 3
- A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingNCT04624659Phase 3
- Observational Study of Home Administration of CarfilzomibWithdrawnNCT04621955
- GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLTerminatedNCT04601584Phase 1/2
- Examining the Experiences of Children With Blood DisordersCompletedNCT04600609
- Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell DiseaseCompletedNCT04584528Not applicable
- Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell TransplantActive, not recruitingNCT04572815Phase 2
- Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood CellsStatus unknownNCT04551235
- Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological DiseasesCompletedNCT04526405
- Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")CompletedNCT04474678Not applicable
- Registry of Patients With Hematologic Disease and COVID-19 in RussiaCompletedNCT04422470
- Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCTCompletedNCT04412811
- ALLO-SCT in Elderly Patients With Hematological DiseaseCompletedNCT04386928
- PK of SOF/LED in HCV - Infected Adolescents With Haematological DisordersStatus unknownNCT04353986Phase 3
- Natural Killer Cell (CYNK-001) Infusions in Adults with AMLTerminatedNCT04310592Phase 1
- Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaStatus unknownNCT04309084Phase 1
- CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWithdrawnNCT04282174Phase 2
- Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse EventsCompletedNCT04279470
- AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)CompletedNCT04272554
- A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTEWithdrawnNCT04258683Phase 2
- PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant PatientsStatus unknownNCT04243434Phase 1
- Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and BiopsyCompletedNCT04168983Not applicable
- Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantActive, not recruitingNCT04167683
- Safety and Tolerability Evaluation of MaaT033CompletedNCT04150393Phase 1
- Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantationWithdrawnNCT04127721Phase 2
- AZA + Venetoclax as Maintenance Therapy in Patients With AML in RemissionTerminatedNCT04062266Phase 2
- Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological DiseaseCompletedNCT04039100Not applicable
- Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail PatientsStatus unknownNCT03920735
- Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell TransplantationCompletedNCT03918343Not applicable
- An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia BCompletedNCT03901755
- Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer PatientsCompletedNCT03895918Not applicable
- Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow TransplantCompletedNCT03886909Not applicable
- Cystatin c and Beta 2 Microglobulin in Thalassemic Children.Status unknownNCT03881917
- Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A ParticipantsCompletedNCT03876301